NCT06494397View on ClinicalTrials.gov

Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 11, 2024

Primary Completion Date

October 24, 2024

Study Completion Date

October 24, 2024

Conditions
SchizophreniaBipolar I Disorder
Interventions
DRUG

VHX-896 and iloperidone

oral tablet

DRUG

Iloperidone and VHX-896

oral tablet

Trial Locations (3)

20877

Vanda Investigational Site, Gaithersburg

90720

Vanda Investigational Site, Los Alamitos

08053

Vanda Investigational Site, Marlton

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY